Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Sep:127:15-24.
doi: 10.1016/j.ejim.2024.07.017. Epub 2024 Jul 21.

Ischemia with non-obstructive coronary artery (INOCA): Non-invasive versus invasive techniques for diagnosis and the role of #FullPhysiology

Affiliations
Review

Ischemia with non-obstructive coronary artery (INOCA): Non-invasive versus invasive techniques for diagnosis and the role of #FullPhysiology

Stefano Benenati et al. Eur J Intern Med. 2024 Sep.

Abstract

Ischemia with non-obstructive coronary arteries (INOCA) is an increasingly recognized entity. It encompasses different pathophysiological subtypes (i.e., endotypes), including coronary microvascular dysfunction (CMD), vasospastic angina (VSA) and mixed entities resulting from the variable combination of both. Diagnosing INOCA and precisely characterizing the endotype allows for accurate medical treatment and has proven prognostic implications. A breadth of diagnostic technique is available, ranging from non-invasive approaches to invasive coronary angiography adjuvated by functional assessment and provocative tests. This review summarizes the strength and limitations of these methodologies and provides the rationale for the routine referral for invasive angiography and functional assessment in this subset of patients.

Keywords: ANOCA; Coronary flow reserve; Coronary microcirculation; Coronary physiology; INOCA; Index of microvascular resistance.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest statement Prof. Porto reports consultant or speaker fees from Medtronic, Abbott Vascular, Edwards, ABIOMED, GE, Siemens Healthcare, Sanofi, Amgen, Daiichi-Sankyo, Astra Zeneca, Bayer, and PIAM, not related to this work. Prof. Gianluca Campo reports research grants from SMT, Siemens Healthcare, GADA, Abbott Vascular, Insight Lifetech. Dr. Benenati reports speaker fees from Amgen. Other authors have nothing to disclose.

MeSH terms

LinkOut - more resources